Clinical trials for Polycythemia vera
20 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGN/ANCT07362225MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)MPN Research Foundation · PI: Raajit Rampal, MD, PhD
- RECRUITINGPhase 2NCT07232290Phase IIa Study on Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia VeraChengdu Zenitar Biomedical Technology Co., Ltd · PI: Lei Zhang, Doctor
- RECRUITINGPhase 2NCT06985147A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)Disc Medicine, Inc · PI: Will Savage, MD PhD
- RECRUITINGNCT06743035Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic SplenomegalyiOMEDICO AG · PI: Eyck von der Heyde, Dr.
- RECRUITINGNCT06752941LOW-PV ContinuationFROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS · PI: TIZIANO BARBUI, MD
- RECRUITINGPhase 3NCT06093672Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia VeraItalfarmaco
- RECRUITINGPhase 1NCT06752746A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia VeraMabwell (Shanghai) Bioscience Co., Ltd.
- ACTIVE NOT RECRUITINGPhase 3NCT06033586Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia VeraProtagonist Therapeutics, Inc.
- RECRUITINGPhase 2NCT05870475Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PVInstitute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, MD
- ACTIVE NOT RECRUITINGNCT05548062Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia VeraNovartis Pharmaceuticals · PI: Novartis Pharmaceuticals
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05499013Study to Assess SLN124 in Patients With Polycythemia VeraSilence Therapeutics plc
- ACTIVE NOT RECRUITINGPhase 3NCT05481151A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PVPharmaEssentia · PI: Ole Zagrijtschuk, MD, PhD
- ACTIVE NOT RECRUITINGNCT06506084Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS · PI: TIZIANO BARBUI, MD
- RECRUITINGNCT05396170Effect of Phlebotomy on Heartrate in Polycythemia PatientsLeiden University Medical Center · PI: Jaap Jan Zwaginga, MD, PhD
- ACTIVE NOT RECRUITINGPhase 3NCT05210790A Phase 3 Study of Rusfertide in Patients With Polycythemia VeraProtagonist Therapeutics, Inc.
- ACTIVE NOT RECRUITINGPhase 2NCT05485948A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HUPharmaEssentia · PI: Jingjing Zhang
- ACTIVE NOT RECRUITINGPhase 3NCT04717414An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell TransfusionsCelgene · PI: Bristol-Myers Squibb
- RECRUITINGPhase 3NCT04655092Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET PatientsPharmaEssentia Japan K.K. · PI: Keita Kirito, MD
- RECRUITINGPhase 3NCT04116502MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia VeraUniversity of Birmingham · PI: Claire Harrison
- ACTIVE NOT RECRUITINGPhase 2NCT02577926The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential ThrombocythemiaRWTH Aachen University · PI: Steffen Koschmieder, Prof. Dr.